SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: DTselentis who wrote (2079)7/17/1998 5:38:00 PM
From: Scott H. Davis  Read Replies (2) | Respond to of 4676
 
Wednesday, July 22 8 am: Advisory committee to the Food and Drug Administration meets to discuss a new drug application for Vitravene by ISIS Pharmaceuticals (ISIP) for treatment of cytomegalovirus retinitis in AIDS patients, at the Holiday Inn, Bethesda, Md.
FYI Scott